The recent inclusion of hemoglobinopathies in the Global Burden of Disease Study and the assessment of the burden of α-thalassemia in terms of DALYs will be meaningful only if contemporary and reliable data are available .
The recent inclusion of hemoglobinopathies in the Global Burden of Disease Study and the assessment of the burden of α-thalassemia interms of DALYs will be meaningful only if contemporary and reliable data are available.